Clinical Trial Update: A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapies [Phase 1]

View source ↗

Summary

This document reports on the status update for a Phase 1 trial of Bleximenib in combination with AML-directed therapies for acute myeloid leukemia, with the tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Bleximenib (Bleximenib)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Leukemia, Myeloid, Acute | Phase 1 | Status: ACTIVE_NOT_RECRUITING